Proven engine, fuel already in the tank: a working growth driver plus already-held means to multiply it
The model's full reasoning — Q3 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks: Does management describe BOTH of the following about the SAME part of the business, as one connected present-tense story? (1) A PROVEN, ALREADY-PRODUCING GROWTH ENGINE THAT IS STILL SMALL RELATIVE TO ITS ROOM. Management identifies a specific driver of growth that is ALREADY generating real business today, and conveys that this driver has so far captured only a small part of what it can reach. (2) THE MEANS TO MULTIPLY IT ARE ALREADY IN THE COMPANY'S HANDS. Management describes resources the company ALREADY possesses or has ALREADY secured that it is now using to scale that same driver up. We need to find if there is such a description in the transcript. The transcript covers Surmodics' Q3 2018 earnings call. They discuss various products, including SurVeil drug-coated balloon, thrombectomy technology, etc. But we need to find a specific growth engine that is already producing revenue and has room to grow, and the company already has the means to scale it. Let's examine the transcript. They talk about the SurVeil agreement with Abbott, which generates revenue. They mention $1.7 million of revenue from SurVeil in the quarter. They also mention that they expect more revenue from that. But is that described as a growth engine that is still small relative to its room? They talk about the partnership with Abbott, but they don't explicitly say that it's early and has captured a small part of its potential. They do say they are prioritizing resources to support this project, and they expect to complete enrollment by end of fiscal 2019. But they don't describe it as a proven growth engine with a small share of its opportunity. They talk about the market for drug-coated balloons, but not in terms of how much they've captured. Another part: they talk about their whole product solutions pipeline, including .014 and .018 balloon catheters, and microcatheter. They mention that they are progressing towards commercial agreements with several interested parties. But these are not yet generating significant revenue? They mention that they are targeting revenue generation for .014 PTA balloon in fiscal 2019. So that's not yet producing. They also talk about the IVD business, which had 10% growth, but they say it's mid single-digit growth going forward.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| TNET | TriNet Group, Inc. | Q1 2024 | 2024-04-26 | C |
| APYX | Apyx Medical Corporation | Q4 2023 | 2024-03-21 | C |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| OUT | Outfront Media Inc. | Q4 2023 | 2024-02-21 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| NMR | Nomura Holdings, Inc. | Q1 2024 | 2023-08-02 | D |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| HBAN | Huntington Bancshares Incorporated | Q4 2022 | 2023-01-20 | B |
| WGO | Winnebago Industries, Inc. | Q1 2023 | 2022-12-16 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| HLNE | Hamilton Lane Incorporated | Q1 2023 | 2022-08-02 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| VVV | Valvoline Inc. | Q1 2022 | 2022-02-09 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| CPRX | Catalyst Pharmaceuticals, Inc. | Q2 2021 | 2021-08-10 | C+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| JPM | JPMorgan Chase & Co. | Q2 2021 | 2021-07-13 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| STM | STMicroelectronics NV | Q3 2018 | 2018-10-24 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| NOVT | Novanta Inc. | Q4 2017 | 2018-05-12 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| FI | Fiserv, Inc. | Q4 2017 | 2018-02-27 | C |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| UAA | Under Armour, Inc. | Q3 2017 | 2017-10-31 | F |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
NMR · Q1 2024 → YESThe question is whether management describes BOTH a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...YES The transcript shows management describing the Retail business as a growth engine that's already producing real results (net revenue up 22%, income up 133% after reorganization in March, recurring and flow revenue benefits starting to appear) but still small relative to its room (only 1,600 partners deployed out of a much larger potential base, with Q-on-Q progress negative from uncontacted clients, and explicit statements like "if we can broaden our partner base, then we will start to see the benefit" and "we have not been able to contact all clients").
OWL · Q2 2021 → YESThe question is whether management describes BOTH a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...YES The transcript shows management describing Direct Lending as a proven growth engine already producing real activity ($5.1 billion gross deployments in the quarter, $31 billion AUM) while still small relative to its opportunity (explicitly "very small relative to total market opportunity" with a $300 billion market and $1. 5 trillion PE dry powder). They connect this directly to the means already in hand: existing sponsor relationships (500), $8.
WRBY · Q1 2024 → YESThe question is: Does management describe BOTH of a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...